You are here

Novartis cancer drug may also work for Parkinson's

A small dose of the Novartis drug Tasigna was found to produce "meaningful clinical improvements" inĀ 10 out of 11 patients with Parkinson's disease.


A NOVARTIS AG drug used for treating leukemia may also work for patients with Parkinson's disease, judging from one small and early clinical test.

An early stage trial conducted by the Georgetown University Medical Center found a small dose of the medicine, Tasigna, produced...

Market voices on: